BioScrip Inc (BIOS) Upgraded to “Hold” at Zacks Investment Research

MicroCap Magazine-4 hours ago

Its segments include Infusion Services and Pharmacy Benefit Management (NASDAQ:BIOS) Services. 12 Month Chart for NASDAQ:BIOS. document.write(' ');.

What's BioScrip Inc Downside After Today's Huge Decline?
Franklin Independent-12 hours ago

Explore in depth (7 more articles)